Volume 59, Issue 3, Pages (March 2001)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 64, Issue 6, Pages (December 2003)
Volume 74, Issue 11, Pages (December 2008)
Osteopontin expression in acute renal allograft rejection
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.
Volume 53, Issue 4, Pages (April 1998)
Volume 79, Issue 6, Pages (March 2011)
Volume 88, Issue 3, Pages (September 2015)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 87, Issue 4, Pages (April 2015)
Volume 67, Issue 1, Pages (January 2005)
Chronic rejection of mouse kidney allografts
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Volume 74, Issue 11, Pages (December 2008)
Volume 80, Issue 10, Pages (November 2011)
Volume 61, Issue 3, Pages (March 2002)
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
Volume 73, Issue 5, Pages (March 2008)
Volume 58, Issue 4, Pages (October 2000)
Volume 70, Issue 2, Pages (July 2006)
Volume 66, Issue 1, Pages (July 2004)
Volume 84, Issue 4, Pages (October 2013)
Volume 63, Issue 2, Pages (February 2003)
Volume 54, Issue 6, Pages (January 1998)
Volume 55, Issue 4, Pages (April 1999)
Single-dose rosuvastatin ameliorates lung ischemia–reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage.
Volume 67, Issue 6, Pages (June 2005)
Volume 54, Issue 5, Pages (November 1998)
Volume 61, Issue 3, Pages (March 2002)
Volume 61, Issue 3, Pages (March 2002)
Volume 62, Issue 2, Pages (August 2002)
Proteasome inhibitor-based therapy for antibody-mediated rejection
Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin 
Volume 56, Issue 3, Pages (September 1999)
Volume 55, Issue 6, Pages (June 1999)
A role for leukotrienes in cyclosporine nephrotoxicity
Volume 70, Issue 6, Pages (September 2006)
Volume 62, Issue 2, Pages (August 2002)
Erythropoietin, progenitors, and repair
Volume 56, Issue 6, Pages (December 1999)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Figure 4. p38α mitogen-activated protein kinase (MAPK) blockade reduces interstitial volume in obstructed kidneys but does not reduce the number of infiltrating.
Volume 64, Issue 3, Pages (September 2003)
Volume 56, Issue 5, Pages (November 1999)
Volume 74, Issue 11, Pages (December 2008)
Volume 59, Issue 5, Pages (May 2001)
Role of the T-cell receptor in kidney ischemia–reperfusion injury
Volume 60, Issue 6, Pages (December 2001)
Volume 82, Issue 11, Pages (December 2012)
Fibrosis and renal aging
Volume 76, Issue 12, Pages (December 2009)
Volume 71, Issue 12, Pages (June 2007)
Organ transplantation goes to the movies
Volume 58, Issue 4, Pages (October 2000)
Volume 62, Issue 1, Pages (July 2002)
Volume 58, Issue 5, Pages (November 2000)
Volume 70, Issue 3, Pages (August 2006)
Jeffrey Damman, Marc A. Seelen  Kidney International 
The more or less ‘pristine’ renal allograft biopsy
Volume 60, Issue 3, Pages (September 2001)
Volume 64, Issue 6, Pages (December 2003)
Volume 65, Issue 3, Pages (March 2004)
Volume 61, Issue 4, Pages (April 2002)
T cells and T-cell receptors in acute renal failure
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status  Kathryn J. Tinckam, Ognjenka Djurdjev, Alex.
Volume 62, Issue 2, Pages (August 2002)
Volume 72, Issue 12, (December 2007)
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Volume 59, Issue 3, Pages 1142-1148 (March 2001) Cold ischemia augments allogeneic-mediated injury in rat kidney allografts  Ewout A. Kouwenhoven, Ron W.F. De Bruin, Ingeborg M. Bajema, Richard L. Marquet, Jan N.M. Ijzermans  Kidney International  Volume 59, Issue 3, Pages 1142-1148 (March 2001) DOI: 10.1046/j.1523-1755.2001.0590031142.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Histologic degree of rejection in ischemic kidney allografts. Allografts preserved for 24 hours demonstrated a higher degree of interstitial cell infiltration at days 3 and 4 after transplantation (▪) than nonischemic allografts (□). In addition, the onset of tubulitis was earlier, which attained a significance at day 4. In isografts, ischemia led to minimal histologic changes: Both in ischemic and nonischemic isografts, the BANFF scores were 0 (*P < 0.05). Kidney International 2001 59, 1142-1148DOI: (10.1046/j.1523-1755.2001.0590031142.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 (A) Normal tubulointerstitium of a kidney isograft at day 3 post-transplantation. (B) Lysosomal enzymes in tubulus cells of a 24-hour preserved kidney isograft at day 3. (C) Mild tubulitis and cellular infiltration in a nonischemic kidney allograft at day 3. (D) Moderate to severe tubulitis and cellular infiltration in a 24-hour preserved kidney allograft at day 3. (E) A normal intraparenchymal artery in a nonischemic kidney allograft at day 4. (F) Endothelial swelling and perivascular infiltration in a 24-hour preserved kidney allograft at day 4. Kidney International 2001 59, 1142-1148DOI: (10.1046/j.1523-1755.2001.0590031142.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Cell infiltration in ischemic kidney isografts and allografts. In allografts, subjection of the kidney to 24 hours of cold ischemia led to an increased cell infiltration compared with nonischemic controls (*P < 0.05). In the first three days, the increase of CD45+ leukocytes consisted mainly of MHC class II+, CD4+ cells, and ED-1+ macrophages. The peak of CD4+ cells was one day earlier, and the number of cytotoxic CD8+ T cells was higher at day 4. By day 6, the difference in cell infiltration between both groups had disappeared. Cell infiltration into ischemic isografts was also increased from day 3 and onward compared with nonischemic isografts, except for CD8+ T-cells (#P < 0.05). The increased infiltration of MHC class II+ and CD4+ cells after ischemia was significantly higher in allografts than in isografts at days 2 and 3 post-transplantation when compared with their nonischemic counterparts (XP < 0.05). Symbols are: (□, solid line) allograft; (▪, solid line) allograft and 24 hours ischemia; (○, dotted line) isograft; (•) isograft 24 hours after ischemia. Kidney International 2001 59, 1142-1148DOI: (10.1046/j.1523-1755.2001.0590031142.x) Copyright © 2001 International Society of Nephrology Terms and Conditions